Free Trial

Forian (NASDAQ:FORA) Shares Up 2.9% - Here's Why

Forian logo with Medical background

Forian Inc. (NASDAQ:FORA - Get Free Report) shot up 2.9% during trading on Thursday . The company traded as high as $2.13 and last traded at $2.12. 3,201 shares traded hands during trading, a decline of 81% from the average session volume of 16,547 shares. The stock had previously closed at $2.06.

Forian Stock Performance

The firm has a market capitalization of $66.15 million, a P/E ratio of -23.56 and a beta of 1.02. The stock has a 50-day moving average of $2.04 and a 200 day moving average of $2.12.

Forian (NASDAQ:FORA - Get Free Report) last announced its quarterly earnings data on Wednesday, May 14th. The company reported ($0.04) EPS for the quarter, missing analysts' consensus estimates of $0.02 by ($0.06). The business had revenue of $7.06 million during the quarter, compared to analysts' expectations of $5.37 million.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Virtu Financial LLC bought a new position in Forian in the 4th quarter valued at $30,000. Renaissance Technologies LLC boosted its position in Forian by 48.9% in the 4th quarter. Renaissance Technologies LLC now owns 35,301 shares of the company's stock valued at $73,000 after buying an additional 11,601 shares during the last quarter. Finally, Oracle Investment Management Inc. boosted its position in Forian by 0.7% in the 4th quarter. Oracle Investment Management Inc. now owns 1,366,107 shares of the company's stock valued at $2,814,000 after buying an additional 10,000 shares during the last quarter. 19.25% of the stock is currently owned by institutional investors.

About Forian

(Get Free Report)

Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Forian Right Now?

Before you consider Forian, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Forian wasn't on the list.

While Forian currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines